...
search icon
snse-img

Sensei Biotherapeutics Inc Share Price

SNSE
NAQ
$10.08
+$0.14
(1.41%)
1D
Industry: Biotechnology Sector: Health Care

Sensei Biotherapeutics Inc Analyst Forecast

Sensei Biotherapeutics Inc Share Price Chart

Sensei Biotherapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.54M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
49.20K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.28
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5 L
$18.35 H
$10.08

About Sensei Biotherapeutics Inc, Common Stock

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland. more

Industry: BiotechnologySector: Health Care

Sensei Biotherapeutics Inc Stock Returns

Time FrameSNSESectorS&P500
1-Week Return7.12%-1.78%1.49%
1-Month Return12.12%-0.23%1.12%
3-Month Return5.77%6.88%1.27%
6-Month Return44%14.9%9.27%
1-Year Return2.44%6.09%15.09%
3-Year Return-64.76%18.07%73.73%
5-Year Return-97.33%34%84.28%

Sensei Biotherapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue209.00K685.00K1.81M571.00K551.00K[{"date":"2020-12-31","value":11.56,"profit":true},{"date":"2021-12-31","value":37.89,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":31.58,"profit":true},{"date":"2024-12-31","value":30.48,"profit":true}]
Gross Profit(209.00K)(685.00K)(1.81M)(571.00K)(551.00K)[{"date":"2020-12-31","value":-20900000,"profit":false},{"date":"2021-12-31","value":-68500000,"profit":false},{"date":"2022-12-31","value":-180800000,"profit":false},{"date":"2023-12-31","value":-57100000,"profit":false},{"date":"2024-12-31","value":-55100000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses19.24M36.80M50.19M36.49M31.11M[{"date":"2020-12-31","value":38.34,"profit":true},{"date":"2021-12-31","value":73.32,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":72.71,"profit":true},{"date":"2024-12-31","value":61.99,"profit":true}]
Operating Income(19.45M)(37.48M)(50.19M)(37.06M)(31.66M)[{"date":"2020-12-31","value":-1945100000,"profit":false},{"date":"2021-12-31","value":-3748200000,"profit":false},{"date":"2022-12-31","value":-5018800000,"profit":false},{"date":"2023-12-31","value":-3706400000,"profit":false},{"date":"2024-12-31","value":-3166300000,"profit":false}]
Total Non-Operating Income/Expense(2.34M)818.00K3.16M6.46M3.97M[{"date":"2020-12-31","value":-36.18,"profit":false},{"date":"2021-12-31","value":12.66,"profit":true},{"date":"2022-12-31","value":48.96,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":61.36,"profit":true}]
Pre-Tax Income(20.10M)(36.79M)(48.59M)(34.10M)(30.16M)[{"date":"2020-12-31","value":-2010000000,"profit":false},{"date":"2021-12-31","value":-3679400000,"profit":false},{"date":"2022-12-31","value":-4858800000,"profit":false},{"date":"2023-12-31","value":-3410100000,"profit":false},{"date":"2024-12-31","value":-3015700000,"profit":false}]
Income Taxes529.00K670.00K219.00K100.00K-[{"date":"2020-12-31","value":78.96,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":32.69,"profit":true},{"date":"2023-12-31","value":14.93,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(20.63M)(37.46M)(48.81M)(34.20M)-[{"date":"2020-12-31","value":-2062900000,"profit":false},{"date":"2021-12-31","value":-3746400000,"profit":false},{"date":"2022-12-31","value":-4880700000,"profit":false},{"date":"2023-12-31","value":-3420100000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(20.10M)(36.79M)(48.59M)(38.92M)(30.16M)[{"date":"2020-12-31","value":-2010000000,"profit":false},{"date":"2021-12-31","value":-3679400000,"profit":false},{"date":"2022-12-31","value":-4858800000,"profit":false},{"date":"2023-12-31","value":-3891900000,"profit":false},{"date":"2024-12-31","value":-3015700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(20.10M)(36.79M)(48.81M)(34.10M)(30.16M)[{"date":"2020-12-31","value":-2010000000,"profit":false},{"date":"2021-12-31","value":-3679400000,"profit":false},{"date":"2022-12-31","value":-4880700000,"profit":false},{"date":"2023-12-31","value":-3410100000,"profit":false},{"date":"2024-12-31","value":-3015700000,"profit":false}]
EPS (Diluted)(23.52)(1.36)(1.58)(1.22)(1.16)[{"date":"2020-12-31","value":-2352.22,"profit":false},{"date":"2021-12-31","value":-136,"profit":false},{"date":"2022-12-31","value":-158,"profit":false},{"date":"2023-12-31","value":-122,"profit":false},{"date":"2024-12-31","value":-116.28,"profit":false}]

Sensei Biotherapeutics Inc Ratios

Sensei Biotherapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SNSE
Cash Ratio 5.64
Current Ratio 5.81

Sensei Biotherapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SNSE
ROA (LTM) -37.04%
ROE (LTM) -70.18%

Sensei Biotherapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SNSE
Debt Ratio Lower is generally better. Negative is bad. 0.17
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.83

Sensei Biotherapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SNSE
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.58
Price/FCF NM
EV/R 0.00
EV/Ebitda 1.36

FAQs

What is Sensei Biotherapeutics Inc share price today?

Sensei Biotherapeutics Inc (SNSE) share price today is $10.08

Can Indians buy Sensei Biotherapeutics Inc shares?

Yes, Indians can buy shares of Sensei Biotherapeutics Inc (SNSE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNSE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Sensei Biotherapeutics Inc be purchased?

Yes, you can purchase fractional shares of Sensei Biotherapeutics Inc (SNSE) via the Vested app. You can start investing in Sensei Biotherapeutics Inc (SNSE) with a minimum investment of $1.

How to invest in Sensei Biotherapeutics Inc shares from India?

You can invest in shares of Sensei Biotherapeutics Inc (SNSE) via Vested in three simple steps:

  • Click on Sign Up or Invest in SNSE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Sensei Biotherapeutics Inc shares
What is Sensei Biotherapeutics Inc 52-week high and low stock price?

The 52-week high price of Sensei Biotherapeutics Inc (SNSE) is $18.35. The 52-week low price of Sensei Biotherapeutics Inc (SNSE) is $5.

What is Sensei Biotherapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Sensei Biotherapeutics Inc (SNSE) is

What is Sensei Biotherapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Sensei Biotherapeutics Inc (SNSE) is 0.58

What is Sensei Biotherapeutics Inc dividend yield?

The dividend yield of Sensei Biotherapeutics Inc (SNSE) is 0.00%

What is the Market Cap of Sensei Biotherapeutics Inc?

The market capitalization of Sensei Biotherapeutics Inc (SNSE) is $12.54M

What is Sensei Biotherapeutics Inc's stock symbol?

The stock symbol (or ticker) of Sensei Biotherapeutics Inc is SNSE

How Can Investors Use Sensei Biotherapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Sensei Biotherapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Sensei Biotherapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Sensei Biotherapeutics Inc shares for Indian investors?

When investing in Sensei Biotherapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Sensei Biotherapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Sensei Biotherapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Sensei Biotherapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Sensei Biotherapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top